Recently Viewed
Clear All$7.95
$0.00 (0.00%)As on 02-Jun-2022 09:30EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$221 Mln
Revenue (TTM)
$-- Mln
Net Profit (TTM)
$-- Mln
ROE
0 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1
Industry P/E
--
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
--
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
27,774,400
CFO
$-202.51 Mln
EBITDA
$23.92 Mln
Net Profit
$23.74 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nuveen Credit Opportunities 2022 Target Term Fund (JCO)
| 1.6 | 0.7 | 0.8 | -2.4 | -0.5 | 1.3 | -- |
|
BSE Sensex*
| -15.4 | -11.9 | -15.9 | -5.8 | 6.7 | 7.4 | 11.0 |
|
Company
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|
|
Nuveen Credit Opportunities 2022 Target Term Fund (JCO)
| 6.1 | -14.3 | 25.7 | -5.3 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 |
|
BSE Sensex
| 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nuveen Credit Opportunities 2022 Target Term Fund (JCO)
|
8.0 | 220.8 | 9.0 | 8.8 | -- | 3.9 | -- | 1.0 |
| 19.6 | 5,146.4 | 2,318.2 | 716.7 | 38.9 | 21.8 | -- | 0.0 | |
| 17.9 | -- | 8.2 | 17.5 | -38.0 | 4.4 | -- | 0.0 | |
| 8.7 | 14,152.8 | 2,870.2 | 78.8 | 19.3 | 3.6 | 90.7 | 2.8 | |
| 15.3 | 4,386.3 | 319.0 | -288.6 | 1.2 | -- | -- | 0.0 | |
| 97.0 | 5,462.6 | 763.4 | 233.5 | 57.2 | 14.7 | 17.4 | 5.0 | |
| 104.8 | 7,249.0 | 6,683.0 | 27.0 | 0.1 | 0.3 | -- | 0.8 | |
| 78.0 | 9,453.6 | 2,297.4 | 715.3 | 35.8 | 30.4 | 13.7 | 3.9 | |
| 47.0 | 5,813.6 | 1,782.8 | -546.5 | -49.5 | -- | -- | 31.7 | |
| 67.0 | 6,366.4 | 7,496.0 | 654.0 | 0.0 | 14.6 | 10.6 | 1.2 |
Nuveen Credit Opportunities 2022 Target Term Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors, LLC and Symphony Asset Management. It invests in fixed income markets of... the United States. The fund primarily invests in corporate debt securities including bonds and senior loans. It invests in investment grade fixed income securities rated BBB- or higher by S&P with a maturity date on June 1, 2022. The fund employs a fundamental analysis with bottom-up stock picking approach while focusing on factors such as sector dynamics, company business models and asset quality and analysis of the relative value to create its portfolio. Nuveen Credit Opportunities 2022 Target Term Fund was formed on September 28, 2016 and is domiciled in the United States. Read more
Headquarters
Chicago, IL
Website
The share price of Nuveen Credit Opportunities 2022 Target Term Fund (JCO) is $7.95 (NYSE) as of 02-Jun-2022 09:30 EDT. Nuveen Credit Opportunities 2022 Target Term Fund (JCO) has given a return of -0.47% in the last 3 years.
Since, TTM earnings of Nuveen Credit Opportunities 2022 Target Term Fund (JCO) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
The 52-week high and low of Nuveen Credit Opportunities 2022 Target Term Fund (JCO) are Rs -- and Rs -- as of 02-Apr-2026.
Nuveen Credit Opportunities 2022 Target Term Fund (JCO) has a market capitalisation of $ 221 Mln as on 02-Jun-2022. As per SEBI classification, it is a company.
Before investing in Nuveen Credit Opportunities 2022 Target Term Fund (JCO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.